# Hydroxyzine Pamoate

NDC: 51655-252
Generic name: Hydroxyzine Pamoate
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230425

FDA application: ANDA088487

## Active ingredients

- HYDROXYZINE PAMOATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-252"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-252
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=faf7932b-40ee-8822-e053-6394a90a5e40